INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Stock Price, Financials & Summary

Price chart

Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4

Key dataNov 4, 2026

Open$13.97

From 52W high−26.42%

Volume459192.00

Market cap$1.14B

P/E (TTM)87.0x

P/S (TTM)0.7x

Div yield—

Key dataNov 4, 2026

Open

$13.97

From 52W high

−26.42%

Volume

459192.00

Market cap

$1.14B

ValuationView details →

P/E (Fwd)

6.3x

EV/EBITDA

12.1x

P/E (TTM)

87.0x

RSI (14)

59.1

MomentumView details →

1D Return

+7.16%

YTD Return

+18.16%

SummaryUpdated Sep 1, 2026

Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a medical device company founded in 1989 and headquartered in Princeton, New Jersey. The company went public in 1995 and has grown through both organic expansion and strategic acquisitions to become a significant player in the neurosurgery, wound care, and surgical reconstruction markets. Integra operates through two main business segments and serves hospitals, surgery centers, and healthcare providers globally with a portfolio of surgical implants, medical instruments, and regenerative tissue products.

Ask drillr about INTEGRA LIFESCIENCES HOLDINGS CORP →

ValuationView details →

P/E (Fwd)

6.3x

P/E (TTM)

87.0x

EV/EBITDA

12.1x

EV/Sales

1.7x

P/S (TTM)

0.7x

P/B (TTM)

1.1x

ProfitabilityView details →

Gross Margin

52.46%

Net Margin

0.79%

EBITDA Margin

14.11%

ROE (TTM)

1.22%

ROA (TTM)

0.37%

Asset Turnover

0.47x

GrowthView details →

Revenue YoY

+0.84%

EPS YoY

+102.59%

FCF YoY

+782.49%

Revenue CAGR 3Y

+1.63%

EPS CAGR 3Y

—

EBITDA YoY

+174.76%

MomentumView details →

1D Return

+7.16%

YTD Return

+18.16%

1Y Return

+28.73%

RSI (14)

59.1

vs 50D SMA

+0.04%

vs 200D SMA

+4.16%

Capital & dividendView details →

Debt/Equity

1.88x

Current Ratio

3.62x

Quick Ratio

2.21x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.59

EPS Surprise

5.92%

Beats (12Q)

10/12

Next Q EPS Est

$0.64

Avg Surprise (4Q)

14.81%

Rev Surprise

−0.48%

Financials snapshotView financials →

Revenue (TTM)

1.66B

Net Income (TTM)

13.01M

Op. CF (TTM)

140.40M

Next earningsFeb 25, 2027 →

Latest newsMore news →

Law Offices of Howard G. Smith said it is conducting a securities-fraud investigation into whether INTEGRA LIFESCIENCES HOLDINGS CORP violated federal securities laws.12d ago

Law Offices of Frank R. Cruz announced an investigation into potential securities fraud claims involving INTEGRA LIFESCIENCES HOLDINGS CORP.13d ago

Similar companies

IRadimed CorporationIRMD SI-BONE, Inc.SIBN Avanos Medical, Inc.AVNS CeriBell, Inc.CBLL Artivion, Inc.AORT AdaptHealth Corp.AHCO Find similar companies →

Latest newsMore news →

Law Offices of Howard G. Smith said it is conducting a securities-fraud investigation into whether INTEGRA LIFESCIENCES HOLDINGS CORP violated federal securities laws.12d ago Law Offices of Frank R. Cruz announced an investigation into potential securities fraud claims involving INTEGRA LIFESCIENCES HOLDINGS CORP.13d ago INTEGRA LIFESCIENCES HOLDINGS CORP reported quarterly earnings of $0.59 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $0.56 per share.14d ago